Skip to main content

Robert Ellis, Colin Brenan, Terrance Bieker, Len Hendrickson, Robert Weltman, Bruce Chabner, Friedrich Christ, Klaus Jrgen Bhm

Premium

Robert Ellis, chief operating officer of BioTrove of Woburn, Mass., has been promoted to president and chief executive officer, the company said. Colin Brenan, BioTrove’s founding CEO, becomes chief technology officer and senior vice president, research and engineering development. Before joining BioTrove in May, Ellis was executive vice president at Affymetrix. Previously, he was president of Genometrix and held senior executive positions at Applied Biosystems and Perkin Elmer where he was president of Applied Biosystems Japan. He holds a BA in chemistry from Hartwick College.


Terrance Bieker on Nov.3 will assume the position of president and chief executive officer of BioSource International of Camarillo, Calif., the company said. Bieker fills the vacancy created by the resignation of Len Hendrickson, who the company announced on Sept. 11 was commencing an indefinite medical disability leave of absence. Robert Weltman, a director of BioSource, has acted as interim CEO. Bieker formerly served as CEO of Axya Medical and president and CEO of Transfusion Technologies. He holds a BS in economics from the University of Minnesota.


Bruce Chabner, clinical director of the cancer center at Massachusetts General Hospital in Boston, has been appointed to the board of directors of Oncotech, a Tustin, Calif., molecular oncology lab services firm. Chabner was formerly director of NCI’s Division of Cancer Treatment for 13 years, during a 25-year tenure at the institute.


Friedrich Christ, senior vice president of BASF, joins of the supervisory board of Axaron Bioscience as chairman, succeeding Klaus J rgen Böhm, the company said. Christ is a business graduate (Dipl.-Kaufmann BWL) and commenced his career at BASF in 1979, culminating as director of the subsidiaries financial control department in late 1998.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.